| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Richard C Breeden is Director at STE. Richard C Breeden's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $9.7M at current prices.
Our model assigns Richard C Breeden a below-average insider score of 26/100, based on 3 past trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -12.6%.
The STE filings lean toward selling, a net 61,348 shares.
Richard C Breeden has 19 Form 4 filings on record from March 2019 to June 2026, all as Director at Steris (STE), 2019–2026.
The 54 reported transactions were 36 option or other derivative awards, 8 open-market sales, 7 option exercises and 3 stock awards.
Counted by filing, the open-market trades come to no purchases and 4 sales worth about $10.3M.
The largest open-market sale was 45,000 shares of STE at an average $153.43 on August 25, 2020, about $6.9M.
None of the 3 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | STE Steris Plc | Director | Sale+OE | 1,481 | $209.51 | $310,284.31 | -3.7% | +10.9% | - | |
| May 16, 2023 | STE Steris Plc | Director | Sell | 12,130 | $208.61 | $2,530,439.30 | -30.2% | +10.2% | +13.2% | |
| May 15, 2023 | STE Steris Plc | Director | Sell | 2,737 | $211.00 | $577,507.00 | -6.4% | +8.7% | +11.9% | |
| Aug 25, 2020 | STE Steris Plc | Director | Sell | 45,000 | $153.43 | $6,904,302.66 | -62.3% | - | - |